Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

for
Solid Tumors, Lymphoma
Location: Cleveland OH
Sponsor: Spectrum Pharmaceuticals, Inc

Sex: All

Age: 0 - 17

Code: NCT04570423

Phase 2, Recruiting

Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses

for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 0+

Code: NCT04050423

Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for
Ovarian Cancer, Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: OnCusp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06234423

Phase 1, Recruiting

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

for
Endometrioid Cancer, Mucinous Ovarian Cancer,
Location: Orlando FL, New Orleans LA, Oklahoma City OK,
Sponsor: University of Oklahoma

Sex: Female

Age: 18 - 70+

Code: NCT05512208

Phase 2, Recruiting

Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Philadelphia PA, Cherry Hill NJ, Sewell NJ,
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05327608

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

for
Solid Tumor, Lymphoma
Location: Morristown NJ, Chicago IL
Sponsor: MultiVir, Inc.

Sex: All

Age: 18+

Code: NCT03544723

Phase 2, Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

for
Solid Tumors, Sarcoma
Location: Boston MA, New York NY, Nashville TN
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644755

Phase 1, Recruiting

The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors

for
Breast Cancer Survivor, Cancer Related Cognitive Difficulties,
Location: Phoenix AZ
Sponsor: Arizona State University

Sex: All

Age: 18+

Code: NCT06938555

Recruiting

Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06246955

Recruiting

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

for
Pediatric Cancer
Location: Hartford CT, Miami FL, Buffalo NY, Tampa FL,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 0+

Code: NCT06423950

Recruiting

EMBRACE: Exercising Together

for
Breast Carcinoma, Prostate Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06049355

Phase 2, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Fairfax VA, Durham NC, Orlando FL,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase 1, Recruiting

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

for
Diagnosis of Cancer of Various Organs
Location: San Diego CA
Sponsor: ClearNote Health

Sex: All

Age: 21 - 70+

Code: NCT03869814

Recruiting

Study of APR-1051 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Brunswick NJ, Fairfax VA, Cleveland OH, Houston TX,
Sponsor: Aprea Therapeutics

Sex: All

Age: 18+

Code: NCT06260514

Phase 1, Recruiting

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

for
Breast Cancer, Muscle Fatigue
Location: Morgantown WV
Sponsor: West Virginia University

Sex: Female

Age: 18+

Code: NCT05013255

Phase 2, Recruiting

Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction

for
Breast Cancer
Location: Gainesville FL
Sponsor: University of Florida

Sex: Female

Age: 18 - 70+

Code: NCT06461650

Recruiting

Perioperative Mindfulness Proposal

for
Breast Cancer, DCIS
Location: Newport Beach CA
Sponsor: Hoag Memorial Hospital Presbyterian

Sex: Female

Age: 18+

Code: NCT04049214

Recruiting

A Study of JNJ-87890387 for Advanced Solid Tumors

for
Neoplasms, Advanced Solid Tumors
Location: Grand Rapids MI, Nashville TN
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06178614

Phase 1, Recruiting

Role of Gut Microbiome in Cancer Therapy

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT05112614

Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Irving TX, Austin TX,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06804824

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial